In women who never had used OCs, the IGF1-19/-19 genotype was associated with a decreased risk of early-onset breast cancer as compared with women who have at least one copy of the 19-repeat allele (IGF1+19) (Cleveland et al, 2006). Here, IGF1 is linked to breast carcinoma.